Personalized regimen for PCSK9 inhibitors: A therapeutic option that maintains efficacy and reduces costs

Personalized regimen for PCSK9 inhibitors: A therapeutic option that maintains efficacy and reduces costs

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Clinical Lipidology - Volume 12, Issue 5, September–October 2018, Pages 1324-1325

Tiziana MD, Federico PhD, Francesco MD, Maddalena PhD, Beatrice MD, Andrea PhD, Michele MD, Roberta Luciani, Mascia Pianelli,